Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seyer Safi

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Lung Cancer (Amsterdam, Netherlands)|October 1, 2018
A new bronchoscopic catheter for the transbronchial ablation of pulmonary nodulesSeyer Safi, Jan Op den Winkel, Steve Kramer, et al.
Insights Into Imaging|January 11, 2014
Primary intrathoracic malignant mesenchymal tumours: computed tomography features of a rare group of chest neoplasmsMarcel Koenigkam-Santos, Gregor Sommer, Michael Puderbach, et al.
Lung Cancer (Amsterdam, Netherlands)|November 28, 2017
C-reactive protein-albumin ratio is an independent prognostic predictor of tumor recurrence in stage IIIA-N2 lung adenocarcinoma patientsYoshikane Yamauchi, Seyer Safi, Thomas Muley, et al.
World Journal of Surgical Oncology|August 8, 2024
Peri- and postoperative morbidity and mortality in older patients with non-small cell lung cancer: a matched-pair studySeyer Safi, Maximilian Robert Gysan, Dorothea Weber, et al.
Oncoimmunology|November 18, 2017
Functional T cells targeting tumor-associated antigens are predictive for recurrence-free survival of patients with radically operated non-small cell lung cancerSeyer Safi, Yoshikane Yamauchi, Anchana Rathinasamy, et al.
BMC Cancer|December 22, 2015
A randomized phase II study of radiation induced immune boost in operable non-small cell lung cancer (RadImmune trial)Seyer Safi, Philipp Beckhove, Arne Warth, et al.
Lung Cancer (Amsterdam, Netherlands)|September 30, 2015
The dynamic pattern of recurrence in curatively resected non-small cell lung cancer patients: Experiences at a single institutionYoshikane Yamauchi, Thomas Muley, Seyer Safi, et al.
Plos One|April 10, 2015
Development and validation of a risk score for predicting death after pneumonectomySeyer Safi, Axel Benner, Janos Walloschek, et al.
BMC Cancer|August 9, 2025
Circulating Hsp70: a tumor biomarker for lymph node metastases and early relapse in thoracic cancerDominik Lobinger, Nicholas Taylor, Verena Messner, et al.
Biomolecules|May 27, 2023
Circulating Hsp70 Levels and the Immunophenotype of Peripheral Blood Lymphocytes as Potential Biomarkers for Advanced Lung Cancer and Therapy Failure after SurgerySeyer Safi, Luis Messner, Merten Kliebisch, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Lung Cancer (Amsterdam, Netherlands)|October 1, 2018
A new bronchoscopic catheter for the transbronchial ablation of pulmonary nodulesSeyer Safi, Jan Op den Winkel, Steve Kramer, et al.
Insights Into Imaging|January 11, 2014
Primary intrathoracic malignant mesenchymal tumours: computed tomography features of a rare group of chest neoplasmsMarcel Koenigkam-Santos, Gregor Sommer, Michael Puderbach, et al.
Lung Cancer (Amsterdam, Netherlands)|November 28, 2017
C-reactive protein-albumin ratio is an independent prognostic predictor of tumor recurrence in stage IIIA-N2 lung adenocarcinoma patientsYoshikane Yamauchi, Seyer Safi, Thomas Muley, et al.
World Journal of Surgical Oncology|August 8, 2024
Peri- and postoperative morbidity and mortality in older patients with non-small cell lung cancer: a matched-pair studySeyer Safi, Maximilian Robert Gysan, Dorothea Weber, et al.
Oncoimmunology|November 18, 2017
Functional T cells targeting tumor-associated antigens are predictive for recurrence-free survival of patients with radically operated non-small cell lung cancerSeyer Safi, Yoshikane Yamauchi, Anchana Rathinasamy, et al.
BMC Cancer|December 22, 2015
A randomized phase II study of radiation induced immune boost in operable non-small cell lung cancer (RadImmune trial)Seyer Safi, Philipp Beckhove, Arne Warth, et al.
Lung Cancer (Amsterdam, Netherlands)|September 30, 2015
The dynamic pattern of recurrence in curatively resected non-small cell lung cancer patients: Experiences at a single institutionYoshikane Yamauchi, Thomas Muley, Seyer Safi, et al.
Plos One|April 10, 2015
Development and validation of a risk score for predicting death after pneumonectomySeyer Safi, Axel Benner, Janos Walloschek, et al.
BMC Cancer|August 9, 2025
Circulating Hsp70: a tumor biomarker for lymph node metastases and early relapse in thoracic cancerDominik Lobinger, Nicholas Taylor, Verena Messner, et al.
Biomolecules|May 27, 2023
Circulating Hsp70 Levels and the Immunophenotype of Peripheral Blood Lymphocytes as Potential Biomarkers for Advanced Lung Cancer and Therapy Failure after SurgerySeyer Safi, Luis Messner, Merten Kliebisch, et al.
Pageof 4